Delix Therapeutics Announces Dosing of First Patient in Phase 1b Clinical Trial for DLX-001 in Major Depressive Disorder [Yahoo! Finance]
FTI Consulting, Inc. (FCN)
Last fti consulting, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
ir.fticonsulting.com
Company Research
Source: Yahoo! Finance
Impact on translational biomarkers and preliminary efficacy following DLX-001 administration to be assessed BEDFORD, Mass., December 04, 2024 BUSINESS WIRE )--Delix Therapeutics, a clinical-stage neuroscience company pioneering novel neuroplasticity-promoting treatments for psychiatric and neurological disorders, today announced that the first patient has been dosed in its Phase 1b clinical trial to evaluate the pharmacodynamics (PD), safety, tolerability, and pharmacokinetics (PK) of DLX-001, a novel non-hallucinogenic neuroplastogen, in Major Depressive Disorder (MDD). "Building on promising preclinical studies that demonstrate DLX-001's ability to rapidly promote robust structural and functional neuroplasticity within hours, as well as sustained therapeutic effects in animal models of depression, the initiation of this trial represents a pivotal milestone in the development of novel treatments for patients suffering from MDD," said Aaron Koenig MD, Chief Medical Officer of Del
Show less
Read more
Impact Snapshot
Event Time:
FCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FCN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FCN alerts
High impacting FTI Consulting, Inc. news events
Weekly update
A roundup of the hottest topics
FCN
News
- FTI Consulting Survey Identifies Renewed Optimism as Healthcare & Life Sciences Sector Embarks on 2025 [Yahoo! Finance]Yahoo! Finance
- FTI Consulting Survey Identifies Renewed Optimism as Healthcare & Life Sciences Sector Embarks on 2025GlobeNewswire
- Change in the Composition of the Exclusive Networks SA Board of Directors [Yahoo! Finance]Yahoo! Finance
- World's Worst Performing Currency Hurts Dollar Borrowers in Brazil [Yahoo! Finance Canada]Yahoo! Finance Canada
- World's Worst Performing Currency Hurts Dollar Borrowers in Brazil [Yahoo! Finance]Yahoo! Finance
FCN
Earnings
- 10/24/24 - Miss
FCN
Sec Filings
- 12/3/24 - Form 4
- 11/7/24 - Form SCHEDULE
- 10/28/24 - Form 8-K
- FCN's page on the SEC website